| Jerome T Kochinsky, DO | |
|
640 S State St, Dover, DE 19901-3530 | |
| (302) 744-6156 | |
| (302) 735-3845 |
| Full Name | Jerome T Kochinsky |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 40 Years |
| Location | 640 S State St, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417973256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C2-0012626 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Winchester Medical Center | Winchester, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Winchester Medical Center | 0244134021 | 124 |
News Archive
A scientist at the University of Arizona College of Medicine - Phoenix has received a $1.65 million grant to find out how a traumatic brain injury changes communication in the brain.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.
MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics was signed, under which Merck Serono would develop new treatments for multiple sclerosis (MS) and other autoimmune conditions based on compounds from Bionomics Kv1.3 program.
› Verified 2 days ago
| Entity Name | Winchester Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679711261 PECOS PAC ID: 0244134021 Enrollment ID: O20031124000061 |
News Archive
A scientist at the University of Arizona College of Medicine - Phoenix has received a $1.65 million grant to find out how a traumatic brain injury changes communication in the brain.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.
MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics was signed, under which Merck Serono would develop new treatments for multiple sclerosis (MS) and other autoimmune conditions based on compounds from Bionomics Kv1.3 program.
› Verified 2 days ago
| Entity Name | Winchester Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487907341 PECOS PAC ID: 7214181585 Enrollment ID: O20130214000243 |
News Archive
A scientist at the University of Arizona College of Medicine - Phoenix has received a $1.65 million grant to find out how a traumatic brain injury changes communication in the brain.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.
MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics was signed, under which Merck Serono would develop new treatments for multiple sclerosis (MS) and other autoimmune conditions based on compounds from Bionomics Kv1.3 program.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jerome T Kochinsky, DO 640 S. State Street, Mail Code 3055, Dover, DE 19901-3530 Ph: (302) 480-1688 | Jerome T Kochinsky, DO 640 S State St, Dover, DE 19901-3530 Ph: (302) 744-6156 |
News Archive
A scientist at the University of Arizona College of Medicine - Phoenix has received a $1.65 million grant to find out how a traumatic brain injury changes communication in the brain.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.
MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics was signed, under which Merck Serono would develop new treatments for multiple sclerosis (MS) and other autoimmune conditions based on compounds from Bionomics Kv1.3 program.
› Verified 2 days ago
Aaron Fedor, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-738-3845 | |
Dr. John P. Gusdon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-735-3845 | |
Dean E. Johnson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-735-3845 | |
Frank Mayer Iii, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-674-4700 Fax: 302-735-3845 | |
Dr. Charles Allen, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1275 So State St, Dover, DE 19901 Phone: 302-678-1302 Fax: 302-678-4550 | |
Dr. Julia Michelle Cullen, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-735-3845 | |
Dr. Lareb Altaf, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6999 |